Study: Fears Of A Rare Side Effect Unfounded In Coronavirus Vaccines
Almost half of Americans say they would not get a COVID-19 vaccine if it were available today, according to a September poll by the Pew Research Center.
COVID-19 Media Briefing: Flu season, COVID-19 and vaccination
Watch as three Duke scholars, including DHVI Chief Operating Officer, Thomas Denny, MSc, MPhil, discuss the intersection of COVID-19 and the upcoming flu season.
Increased demand, efficacy among experts' flu vaccine concerns in COVID-19 era
Manufacturers have ramped up production of the 2020-21 flu vaccine during the COVID-19 pandemic, with the two viruses expected to overlap this winter, and it still may not be enough to meet demand, experts told UPI.
Dean Mary Klotman talks with COVID-19 National Experts
Watch as Dr. Barton Haynes, Director of the Duke Human Vaccine Institute, and Dr. Mark McClellan, Director of the Robert J. Margolis Center for Health Policy, join Dean Mary Klotman to talk about COVID-19 vaccine development and policy.
Duke Human Vaccine Institute to partner with RTI International as Coordinating Center for newly established NIAID-funded Emerging Infectious Diseases Network
The Duke Human Vaccine Institute in partnership with RTI International have been named the coordinating center for the newly established Centers for Research in Emerging Infectious Diseases (CREID) network, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). The coordinating center will serve as the network’s operational hub to streamline and accelerate research response to emerging infectious disease outbreaks.
RTI International to Serve as Coordinating Center for Newly Established NIAID-funded Emerging Infectious Diseases Network
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded RTI International, a nonprofit research institute, in partnership with the Duke Human Vaccine Institute, the coordinating center role for the newly established Centers for Research in Emerging Infectious Diseases (CREID) network. The CREID Coordinating Center will serve as the network’s operational hub to streamline and accelerate research response to emerging infectious disease outbreaks.
NIAID Establishes Centers for Research in Emerging Infectious Diseases
The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, today announced that it has awarded 11 grants with a total first-year value of approximately $17 million to establish the Centers for Research in Emerging Infectious Diseases (CREID).
Meet the team powering Duke's COVID-19 surveillance testing efforts
Students returning to Duke University are participating in surveillance testing to help rapidly identify and isolate people who may have contracted the COVID-19 virus. This is done using pool testing, which combines nasal samples from five people for a single test to allow more testing using fewer resources. If a pooled test comes back positive, each student in that sample will be tested individually to identify who has contracted the virus and follow through with any isolation procedures.
UNC, Duke seek volunteers, particularly people of color, for COVID-19 vaccine trials
UNC Health and the School of Medicine are looking for 500 people willing to test a potential vaccine for COVID-19, one of what could be several opportunities for Triangle residents to take part in vaccine clinical trials for coronavirus in the coming months.
This might be your most important flu shot ever
This fall and winter, health experts expect two types of deadly viruses to be circulating widely in the US. But they don’t yet know what the extent of the damage will be when the two collide.